Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $464036.00.
ENTERPRISE VALUE (EV)
$464036.00
CNS Pharmaceuticals, Inc.
Market Cap
$7.34M
Enterprise Value (EV)
$464036.00
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| CNS Pharmaceuticals, Inc. (CNSP) | $7.34M | $464036.00 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | $5.11M |
| Longeveron Inc. (LGVN)vs › | $7.36M | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.20M | $4.54M |
| KALA BIO, Inc. (KALA)vs › | $7.16M | $6.93M |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.08M | $7.08M |
| Mangoceuticals, Inc. (MGRX)vs › | $7.07M | $7.17M |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.76M | $15.53M |
| Aclarion, Inc. (ACON)vs › | $6.74M | N/A |
Market Cap
$7.34M
Total Debt
$328571.00
Cash
$7.20M
Enterprise Value
$464036.00
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
